Skip to Main Content

Paper Details

Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering.
bioRxiv
2
2020
B cell, CD4, CD4 T cell, COVID, COVID-19, MHC-II, MHC-II T cell, MHC-II T cell promiscuous epitopes, S protein, S protein candidate, S protein variants, SARS-CoV, SARS-CoV-2, SARS-CoV-2 Spike Glycoproteins, SARS-CoV-2 spike (S) protein, T, epitopes, human, human coronaviruses, mutated S protein, native S protein, receptor
Author NameAffiliation
Edison OngUniversity of Michigan ann arbor
Yongqun HeUniversity of Michigan ann arbor
Yongqun HeUniversity of Michigan ann arbor
Yongqun HeUniversity of Michigan ann arbor
Yongqun HeUniversity of Michigan ann arbor
  • 1 - 5

Datasets

Release 1.2